Press release
Coronary Stents Market Sales Estimated to Hit USD 15.7 Billion by 2032| Says Persistence Market Research
The coronary stents market has gained substantial momentum in recent years owing to its critical role in treating coronary artery disease (CAD), one of the leading causes of morbidity and mortality worldwide. Coronary stents, small expandable mesh devices, are widely used in percutaneous coronary interventions (PCI) to restore blood flow in blocked arteries. Known for their effectiveness in reducing restenosis and improving patient outcomes, coronary stents have become a cornerstone in interventional cardiology.
For More Information:
https://www.persistencemarketresearch.com/market-research/coronary-stents-market.asp
This report provides a comprehensive analysis of the coronary stents market, covering growth drivers, challenges, emerging trends, regional insights, and leading market participants. With rising incidences of cardiovascular diseases and increasing adoption of minimally invasive procedures, the demand for advanced stenting solutions continues to accelerate globally.
Market Projections and Forecast
According to Persistence Market Research's projections, the global coronary stents market is set to expand steadily over the next decade. The global coronary stents market size is projected to rise from US$ 10.2 Bn in 2025 to US$ 15.7 Bn by 2032. It is anticipated to witness a CAGR of 6.4% during the forecast period from 2025 to 2032.
The growing burden of lifestyle-related cardiovascular diseases, coupled with continuous innovation in drug-eluting and bioresorbable stents, will play a pivotal role in fueling demand. North America and Asia-Pacific are expected to remain leading regions due to advanced healthcare infrastructure, rising awareness, and increasing healthcare spending.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/3275
Market Dynamics
Drivers of Market Growth
Rising Prevalence of Cardiovascular Diseases
The increasing global incidence of coronary artery disease, driven by sedentary lifestyles, aging populations, and unhealthy diets, is a major factor boosting the demand for coronary stents.
Advancements in Stent Technology
Drug-eluting stents (DES), bioresorbable stents, and next-generation metallic stents are increasingly adopted for their superior efficacy, reduced restenosis rates, and better long-term patient outcomes.
Growing Adoption of Minimally Invasive Procedures
The shift toward minimally invasive interventional cardiology procedures has increased the use of coronary stents, reducing recovery times and hospitalization costs.
Expanding Healthcare Access
Emerging economies are witnessing increased healthcare investments and infrastructure improvements, making advanced cardiac treatments and stent procedures more accessible.
Challenges in the Market
High Cost of Coronary Stent Procedures
Despite technological advancements, coronary stent implantation remains expensive, particularly in low- and middle-income countries, limiting widespread adoption.
Risk of Complications
Stent thrombosis, restenosis, and bleeding complications continue to pose clinical challenges, requiring ongoing innovation in stent design and materials.
Regulatory and Reimbursement Barriers
Stringent approval processes and varying reimbursement frameworks across regions can hinder the adoption of newer stent technologies.
Market Trends and Technological Innovations
Bioresorbable Scaffolds (BRS): Increasing research and adoption of stents that naturally dissolve over time, leaving arteries free of permanent implants.
Next-Generation Drug-Eluting Stents (DES): Stents with improved biocompatibility, thinner struts, and novel drug coatings to reduce complications.
Integration of Imaging and AI: Advanced imaging technologies and artificial intelligence are enhancing precision in stent placement and patient monitoring.
Focus on Emerging Markets: Companies are expanding into Asia-Pacific, Latin America, and Middle East & Africa to capitalize on rising patient pools and growing healthcare investments.
Coronary Stents Market Segmentation
By Product Type
Bare Metal Stents
Drug Eluting Stents
Bioresorbable Vascular Scaffolds (BVS)/Bioresorbable Coronary Stents
Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-user
Inpatient Facilities
Outpatient Facilities
By Region
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Regional Analysis
North America
North America remains a dominant market due to advanced healthcare systems, high prevalence of CAD, and rapid adoption of innovative stent technologies. The U.S. is expected to lead, supported by strong R&D and favorable reimbursement policies.
Europe
Europe accounts for a significant share, driven by high awareness of cardiovascular health, availability of advanced treatment options, and stringent regulatory standards ensuring quality and safety.
Asia-Pacific
Asia-Pacific is projected to witness the fastest growth, fueled by a rising patient pool, increasing healthcare spending, and government initiatives to improve access to advanced cardiac care in countries like China and India.
Latin America
The region is showing steady growth, with Brazil and Mexico emerging as key markets due to improving healthcare infrastructure and growing demand for minimally invasive cardiac procedures.
Middle East & Africa
MEA is expected to show promising growth, supported by increasing healthcare investments, higher prevalence of lifestyle-related diseases, and expanding access to modern cardiac care.
Key Companies Profiled in the Report
Abbott Laboratories
Boston Scientific Corporation
MicroPort Scientific Corporation
Terumo Corporation
Stentys SA
B Braun SE
C. R. Bard, Inc.
Biotronik
Cook Medical
Meril Life Sciences Pvt. Ltd.
Biosensors International Group Limited
Future Outlook
The global coronary stents market is poised for significant growth, supported by rising cardiovascular disease prevalence, ongoing product innovations, and expanding adoption of minimally invasive procedures. Bioresorbable and next-generation drug-eluting stents are expected to lead the future landscape, addressing complications associated with traditional stents.
While high procedure costs and regulatory challenges remain, increasing healthcare investments and growing access to advanced cardiology treatments in emerging markets will unlock new opportunities. The market's long-term growth will be shaped by technological innovations, strategic collaborations, and the global push toward improving cardiovascular health outcomes.
Conclusion
The coronary stents market is undergoing steady expansion, with strong growth prospects across developed and developing regions. As healthcare systems worldwide prioritize early diagnosis and advanced treatment of cardiovascular diseases, coronary stents will remain central to interventional cardiology. With innovation, sustainability, and accessibility driving the next wave of growth, the market is well-positioned to deliver transformative benefits to patients and healthcare providers alike.
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Stents Market Sales Estimated to Hit USD 15.7 Billion by 2032| Says Persistence Market Research here
News-ID: 4191386 • Views: …
More Releases from Persistence Market Research
Electric Bed Market Expands with Rising Demand for Advanced Patient Care Solutio …
The global electric bed market is undergoing a transformative shift, driven by rising healthcare needs, aging demographics, and advancements in medical technology. These motorized beds-equipped with remote control features, adjustable components, and increasingly smart technology-are playing a central role in both clinical and homecare settings. With applications ranging from patient recovery to elderly care, electric beds provide greater mobility, comfort, and safety for users and significantly reduce caregiver burden.
According to…
Dental Simulator Market to Witness Robust Growth Driven by Advancements in Denta …
The global dental simulator market is evolving rapidly, driven by the integration of advanced digital technologies in dental education and the rising demand for skilled dental professionals. Valued at US$ 483.1 million in 2025, the market is projected to grow at a CAGR of 3.9%, reaching US$ 875.7 million by 2032. Dental simulators provide a safe, virtual environment for students and professionals to practice dental procedures like scaling, drilling, and…
Women's Health App Market to Grow with Rising Awareness on Reproductive Health a …
The global women's health app market is undergoing a revolutionary transformation, reshaping how women manage their health, track key life stages, and access digital care. As the demand for personalized, accessible, and secure healthcare solutions continues to rise, this market stands as a crucial pillar of the FemTech revolution. These mobile applications provide a wide array of services ranging from menstrual tracking, fertility monitoring, pregnancy support, to menopause management, mental…
Industrial Hydraulic Equipment Market Driving Power, Precision, and Efficiency i …
Overview of the Market
The global industrial hydraulic equipment market is experiencing steady growth as industries increasingly rely on hydraulic systems for power transmission, precision control, and heavy-duty operations. Valued at approximately USD 28.5 billion in 2024, the market is projected to reach USD 40.6 billion by 2031, recording a CAGR of 5.2% during the forecast period. Industrial hydraulic equipment, including pumps, cylinders, motors, and valves, plays a critical role in…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
